» Articles » PMID: 30808315

Breastfeeding and Vitamin D Supplementation Reduce the Risk of Kawasaki Disease in a German Population-based Case-control Study

Overview
Journal BMC Pediatr
Publisher Biomed Central
Specialty Pediatrics
Date 2019 Feb 28
PMID 30808315
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In Kawasaki disease (KD), a vasculitis of unknown etiology, the most serious complication is the development of coronary artery aneurysm (CAA). To date, the exact pathomechanism of KD is unknown. Both environmental and genetic factors seem to be associated with the development of the disease.

Methods: Data on KD patients recruited from the population-based German Pediatric Surveillance Study during 2012-2014 were used to evaluate the impact of various factors from the perinatal and infancy period on the development of KD. The study design was a matched case-control study with respect to age, sex and place of residence (n = 308 KD cases, n = 326 controls). All KD patients were individually re-evaluated; all fulfilled the international diagnostic KD criteria. A standardized questionnaire was used to review breastfeeding practices, vitamin D supplementation and birth characteristics. Logistic regression analyses were performed to obtain odds ratios (OR) for various risk factors among the case-control pairs. Simple measures of association were used to assess the impact of these factors on the clinical course.

Results: There was no difference in lengths of gestation, birth weight or parturition between KD patients and controls, but independently from each other vitamin D supplementation and breastfeeding were negatively associated with KD, even when adjusted for age, place of residence and sex. The duration of vitamin D was significantly shorter among children with KD than among children without KD (p = 0.039, OR = 0.964, 95% CI: 0.931-0.998), as was the duration of breastfeeding (p = 0.013, OR = 0.471, 95% CI: 0.260-0.853). Comparing KD patients with and without breastfeeding and/or vitamin D supplementation, there were no differences regarding developing CAA, being refractory to intravenous immunoglobulin treatment, age at onset of the disease and levels of inflammatory laboratory values.

Conclusion: Our findings indicate breastfeeding and vitamin D supplementation to have protective effects in association with KD in our study population; however, these seem not to influence the natural course of the disease. Although the overall effects were relatively small, they nevertheless underline the overall benefit of both interventions.

Trial Registration: Clinical Trial Registration: German clinical trial registration, http://apps.who.int/trialsearch/Trial2.aspx?TrialID=DRKS00010071 . Date of registration was 26. February 2016. The trial was registered retrospectively.

Citing Articles

Exploring the Therapeutic Potential of Vitamin D in Kawasaki Disease and Its Interplay with the COVID-19.

Visuddho V, Welliam Y, Aldian F, Tri Arif Sampurna M, Irzaldy A Turk Arch Pediatr. 2024; 59(5):432-439.

PMID: 39439407 PMC: 11391221. DOI: 10.5152/TurkArchPediatr.2024.24141.


COVID-19 infection and metabolic comorbidities: Mitigating role of nutritional sufficiency and drug - nutraceutical combinations of vitamin D.

Mandal S, Tare M, Deepa P Hum Nutr Metab. 2024; 31:200179.

PMID: 38620788 PMC: 9762046. DOI: 10.1016/j.hnm.2022.200179.


The etiologies of Kawasaki disease.

Burns J J Clin Invest. 2024; 134(5).

PMID: 38426498 PMC: 10904046. DOI: 10.1172/JCI176938.


Kawasaki disease and the environment: an enigmatic interplay.

Aggarwal R, Pilania R, Sharma S, Kumar A, Dhaliwal M, Rawat A Front Immunol. 2024; 14:1259094.

PMID: 38164136 PMC: 10757963. DOI: 10.3389/fimmu.2023.1259094.


The Impact of Vitamin D Levels on Clinical Manifestations of Multisystem Inflammatory Syndrome in Children: A Cross-Sectional Study.

Petrovic D, Benzon B, Srsen S, Polic B, Vukovic Novogradec A, Milic P Life (Basel). 2023; 13(3).

PMID: 36983830 PMC: 10057472. DOI: 10.3390/life13030674.


References
1.
Kendrick J, Targher G, Smits G, Chonchol M . 25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey. Atherosclerosis. 2008; 205(1):255-60. DOI: 10.1016/j.atherosclerosis.2008.10.033. View

2.
Duijts L, Jaddoe V, Hofman A, Moll H . Prolonged and exclusive breastfeeding reduces the risk of infectious diseases in infancy. Pediatrics. 2010; 126(1):e18-25. DOI: 10.1542/peds.2008-3256. View

3.
Suzuki Y, Ichiyama T, Ohsaki A, Hasegawa S, Shiraishi M, Furukawa S . Anti-inflammatory effect of 1alpha,25-dihydroxyvitamin D(3) in human coronary arterial endothelial cells: Implication for the treatment of Kawasaki disease. J Steroid Biochem Mol Biol. 2009; 113(1-2):134-8. DOI: 10.1016/j.jsbmb.2008.12.004. View

4.
Ross A, Manson J, Abrams S, Aloia J, Brannon P, Clinton S . The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2010; 96(1):53-8. PMC: 3046611. DOI: 10.1210/jc.2010-2704. View

5.
Newburger J, Takahashi M, Gerber M, Gewitz M, Tani L, Burns J . Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart.... Circulation. 2004; 110(17):2747-71. DOI: 10.1161/01.CIR.0000145143.19711.78. View